NF2 and breast cancer: Exogenous administration of cell‐permeable GSH reduced ROS levels in both, MCF7 KD (Fig. 2A) and T47D KD (Fig. 2B) breast cancer cells, suggestive of a dysfunctional ROS clearance system in context of Merlin deficiency.